נולוג'יקס 250 מ"ג

Land: Israël

Taal: Hebreeuws

Bron: Ministry of Health

Werkstoffen:

BELATACEPT 25 MG/ML

Beschikbaar vanaf:

BRISTOL-MYERS SQUIBB (ISRAEL) LIMITED

ATC-code:

L04AA28

farmaceutische vorm:

POWDER FOR CONCENTRATE FOR INFUSION

Toedieningsweg:

I.V

Geproduceerd door:

BRISTOL-MYERS SQUIBB S.R.L, ITALY

Therapeutische categorie:

BELATACEPT

therapeutische indicaties:

Nulojix, in combination with corticosteroids and mycophenolic acid (MPA), is indicated for prophylaxis of graft rejection in adults receiving a renal transplant. It is recommended to add an interleukin (IL)-2 receptor antagonist for induction therapy to this belatacept-based regimen

Autorisatie datum:

2012-08-01